beta cell inducers (Novomedix)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebeta cell inducers (Novomedix)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRegenerating islet-derived protein 3-alpha agonists
TargetsRegenerating islet-derived protein 3-alpha
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovomedix LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovomedix LLC
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A